ʻO kaʻike kiko'ī no ka maʻi tb a me ke kū'ē iā Rif & nih

ʻO Tucberculosis (TB), i hanaʻia e nā tuarcoctium tuapium, e noho ana i kahi hoʻoweliweli olakino olakino. A me ka paleʻana o ka paleʻana i nā lāʻau tb e like me RIFIMICIN (RIF) a me ISONIAZID (INH) i nā hana nui o Global TB. ʻO Rapid a me ka hōʻikeʻana i ka hōʻike molecular molecular o TB a me ke kū'ēʻana iā Rif & Ith i hōʻikeʻia e ka mea maʻi i halaʻoleʻia.

Mea paʻakikī

Ua manaʻoʻia he 10.6 miliona mau kānaka i hāʻule me ka tb ma 2021 me ka hoʻonuiʻana o ka 4,5% mai ka makahiki he 20,1 i nā makahiki he 138.

ʻO ka lāʻau lapaʻau-resistant tb, kūikawā mdr-tb (ka paleʻana i ka rif & inh), e hoʻonui ana i ka mālamaʻana i ka honua

ʻO Rapid Simuaneous Simuaneous Tb a me RIF / ISH COCONTENT GAGNOSIS i koiʻia e koiʻia no ka hoʻomaʻamaʻaʻana a me ka hana kūpono i nā hopena hoʻokolohua

ʻO kā mākou Pōkuhi

ʻO Marco & Micro-Micro-Secking's 3-in-1tE hiki i ka maʻi kūpono o TB a me RIF / ITH ma kahi kiko'ī hoʻokahi.

Uaʻikeʻo Melloting Curve Technorizes i kaʻikeʻana i ka tb a me mdr-tb.

3-IN-1 TB / TB / MDR-TB EMPE E HOOPONOPONO O TBIE A ME KA LOHE ANA (RIF / INH / INH / ITH).

ʻO ka Myscoctersium Tuacpelesis nuklecle acid a me Rifamhickin

Ke hōʻike nei i ka ho'āʻoʻana i ka Triple Triple Triple

Rapidhopena:Pono ma 1.5-2 mau hola me ka hopena otuttic e wehewehe ai i ka hōʻemiʻana i ka hoʻomaʻamaʻa loea no ka hana;

Hōʻike Hōʻike Manaʻo:1-3 ml sputum;

Kūlā kiʻekiʻe:ʻO keʻano loiloi o 50 balelia / ml no tb a me 2x10³BACTERIA / ML no RIF / ISH resistant Baicteria

ʻO ka pahuhopu lehulehus: Tb-he6110; Rif-pale -rpob (507 ~ 503);

Inh-pale-inha / ahpc / kakap 315;

Ka Manaʻo Kūlana:Kaohiʻana o ka cell no ka hāʻawiʻana i ka manaʻo maikaʻi e hoʻemi i nā hana hewaʻole;

Ka hoʻohālikelike ākea: Kūlike me ka hapa nui o nā'ōnaehana PCR no ka laulā Lab ākea;

ʻO ka mea e hoʻokō pono ai: E pili ana i nā alakaʻi no ka hoʻokeleʻana o ka lāʻau lapaʻau o ka lāʻau lapaʻau-resistantis